SLC1A2 and Cognitive impairment: The intraperitoneal injection of SCH58261 decreased the levels of inflammatory factors and glutamate and increased the levels of GLT-1 and PSD95 in the hippocampus of CP mice, ultimately alleviating cognitive impairment.